Effects of cytochrome P450 3A (CYP3A) and the drug transporters P-glycoprotein (MDR1/ABCB1) and MRP2 (ABCC2) on the pharmacokinetics of lopinavir.
about
Predicting Drug Extraction in the Human Gut Wall: Assessing Contributions from Drug Metabolizing Enzymes and Transporter Proteins using Preclinical ModelsPharmacogenomics Implications of Using Herbal Medicinal Plants on African Populations in Health TransitionLopinavir plasma concentrations and virological outcome with lopinavir-ritonavir monotherapy in HIV-1-infected patientsInfluence of drug transport proteins on the pharmacokinetics and drug interactions of HIV protease inhibitors.Role of P-glycoprotein in the distribution of the HIV protease inhibitor atazanavir in the brain and male genital tract.Canalicular ABC transporters and liver disease.The plasma membrane monoamine transporter (PMAT): Structure, function, and role in organic cation disposition.Renal Drug Transporters and Drug Interactions.The Role of PXR Genotype and Transporter Expression in the Placental Transport of Lopinavir in Mice.Phase II trial of ritonavir/lopinavir in patients with progressive or recurrent high-grade gliomas.In vitro and physiologically-based pharmacokinetic based assessment of drug-drug interaction potential of canagliflozin.Antiretroviral Drug Metabolism in Humanized PXR-CAR-CYP3A-NOG Mice.
P2860
Q26764739-85D9E93D-2A2A-48EF-BF5E-CE5D2DA40F31Q36105822-82A17ABE-3B08-49F3-8D8E-A7AE7E9D2BC5Q37036468-B880A695-9398-42A3-8B56-90B85B0A1C1BQ37113947-578D2532-3594-4767-A51C-2A1E328DD7E6Q37643618-76BD1056-DF82-4204-9CE3-BA21DC0BE756Q37943784-F1EC1927-402E-46D7-8C17-090517BD256EQ38923212-E4C3FE02-98B9-4E22-A7CF-01D91CA6F8ECQ39140289-B2A65F28-9698-47D3-95C6-2934117AB5B1Q47397797-5CBEA4B4-8E95-4310-BFE0-A0DB411E9FAFQ48101081-85F9BD32-EBEF-4A0E-A1EB-2C36BE8DF238Q51060483-9D78AAC6-75A7-4D46-B97A-4216398D8646Q54267469-040ED651-2EDA-451B-AE3D-E3F8E58D7693
P2860
Effects of cytochrome P450 3A (CYP3A) and the drug transporters P-glycoprotein (MDR1/ABCB1) and MRP2 (ABCC2) on the pharmacokinetics of lopinavir.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
Effects of cytochrome P450 3A ...... pharmacokinetics of lopinavir.
@en
Effects of cytochrome P450 3A
@nl
type
label
Effects of cytochrome P450 3A ...... pharmacokinetics of lopinavir.
@en
Effects of cytochrome P450 3A
@nl
prefLabel
Effects of cytochrome P450 3A ...... pharmacokinetics of lopinavir.
@en
Effects of cytochrome P450 3A
@nl
P2093
P2860
P1476
Effects of cytochrome P450 3A ...... pharmacokinetics of lopinavir.
@en
P2093
A D R Huitema
A H Schinkel
C M M van der Kruijssen
E Wagenaar
J H Beijnen
R A B van Waterschoot
R W Rooswinkel
R ter Heine
P2860
P304
P356
10.1111/J.1476-5381.2010.00759.X
P407
P577
2010-07-01T00:00:00Z